No Data
No Data
Emergent to Sell Baltimore-Bayview Facility for $36.5 Million
Express News | Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Press Release: Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Emergent BioSolutions' Earnings Call: Balancing Achievements and Challenges
Emergent BioSolutions | 10-K: FY2024 Annual Report